# A Study to Compare Two Formulations of LY3209590 in Healthy Participants

> **NCT05914688** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 67 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3209590 (Formulation 1)
- **DRUG:** LY3209590 (Formulation 2)

## Key facts

- **NCT ID:** NCT05914688
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-26
- **Primary completion:** 2024-01-18
- **Final completion:** 2024-01-18
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05914688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05914688, "A Study to Compare Two Formulations of LY3209590 in Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05914688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*